Merck & Co., Inc. EVAX Holdings History
Number of Shares
1.21 Mil
Current Holdings Value*
$2.25 Mil
% of Portfolio
1.37%
Total Estimate Gain
$-879,518.64
% of Total Estimate Gain
-21.40%
Merck & Co., Inc.'s Evaxion AS Holding Summary
As of 2025-03-31, Merck & Co., Inc. held 1.21 Mil shares of Evaxion AS(EVAX), totaling $2.25 Mil. This investment constitutes 1.37% of their stock portfolio, and Merck & Co., Inc. now holds 19.21% of the outstanding Evaxion AS(EVAX) stock.
The initial trade took place in 2024Q4. And since then Merck & Co., Inc. has made 1 purchases of EVAX, at an average price of $3.38, for a total of 1.21 Mil shares. Based on historical transaction data and EVAX's current price of $2.66, Merck & Co., Inc.'s estimated gain on his EVAX holdings is $-879,518.64, reflecting a -21.40% gain to date.
Merck & Co., Inc. EVAX ($2.66) Holding Chart
Merck & Co., Inc. EVAX ($2.66) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1